Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.
OAPK: Quite right! Both. A new account with a name change. Almost 2 years ago when I last posted I gave away too much personal info, which made me reluctant to post anything else. I drafted something on 26th March to post vaguely along similar lines after that CIZ RNS but then deleted it before sending. The urge is still there so I posted something this time, altho again I felt like deleting it because it added nothing new and was just emotionally based. Just FYI I've been in CIZ for about 18 months, now have (for me) a sizeable holding, but I've no interested in selling soon nor interested in trying to turn a profit from these short-term ups & downs in the sp over the coming few months, it's what happens to it when the test is out and the breast cancer test approaching that I'm interested in, and that's not going to be dependent on anything that anyone says + or - on these share chat boards. Probably you won't hear from me again! (But maybe the lid is off the bottle now and you'll get several more and not just on CIZ...).
Just a couple of observations, the RNS out on April 2nd actually stated under "Further Information" that "On 26 March 2024, the Company completed a placing raising gross proceeds of £620,000, which will be utilised towards completing Cizzle's first proposed commercial test ..." etc . As the wording states that they "completed a placing raising ..." to me it seems that they've already RNS'd the info about the successful conclusion to it a fortnight ago.
Something else, in the same RNS under the comments section at the end Behnke states: "Our investor group sees this as an important opportunity to make a major difference to lung cancer survival rates and we have already made progress in developing further relationships with major cancer hospitals ..." etc. I get the impression from this and other statements through-out the RNS that things are far more progressed than some commentators on this share chat are giving credit for - the implication from Behnke is that the group of HNWIs has already formed, and maybe has been for some time, given the details in the RNS about what the exact relationship will be between CIZ BIO and CIZ - which includes an already committed upfront payment of $100,000 by the end of April, closely followed by another $300,000 on signing the formal agreement (due at the very latest by July 29th). So it seems to me that CIZ BIO already has the HNWIs signed up, and it's pretty certain that the commercial test works, that CIZ has spent the last few months preparing for the best way to roll it out in a way that doesn't impede the core purpose of CIZ which to carry on with researching other applications for the CIZ1b biomarker (and not having to get bogged down in all the hassle of the commercialisation of it). It looks like this US group are already very clear on the way forward and have already started pressing ahead with preparations for rolling out the test. The relationship CIZ BIO has with CIZ first has to be legally cemented before any green light can be given to Corepath to assess and certify the test but I get the feeling that things are now on the home run, there are very few unknown elements left that make this a risk (but still some potentially important ones, like if a big player suddenly unveils their own new and highly accurate test, albeit unlikely, given how CIZ seems to be being received in medical circles). All this just my opinion, but mostly taken from the RNS and the success of the recent placing confirmed by recent posts from Greend100 & Techtonic.
I just go on instincts with info gleaned from positive and negative contributors, and as it's not hard fact I don't like to post, so I'll take this opportunity to express some deep appreciation to all contributors, especially those solid regular contributors (eg like the two mentioned above), and also the negative ones who give cause for re-assessment... not to forget of course the big daddy who unwittingly caused me to risk heavily in this, Neilin62
Here's what is said:
"Indian opportunity not reflected in Cyanconnode shares, says Crux
Internet of things network provider Cyanconnode (CYAN) has a foothold in the Indian market that will provide ‘strong growth prospects’, says Crux Asset Management’s Richard Penny.
The company is the seventh-largest holding in Penny’s £6m minnow TM Crux UK Special Situations fund, where it makes up 4.3% of assets.
The share price fell in the fourth quarter ‘after raising capital to support additional investment in the rollout of smart meters in India’.
‘The Indian smart metering programme, backed by significant government funding, appears to be on track with c.100m smart meters already awarded to prime bidders and these orders should soon filter down to competitively well-positioned subcontractors such as CyanConnode,’ said Penny.
He added that the opportunity in the Indian market, which could see 250m smart meters rolled out, is offering ‘strong growth prospects for the company’ which are not ‘not reflected in the current valuation’.
Shares in the AIM-listed company retreated 1.5% to 8.08p on Tuesday.
Article ends...